Your browser doesn't support javascript.
loading
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.
Friedl, Thomas W P; Fehm, Tanja; Müller, Volkmar; Lichtenegger, Werner; Blohmer, Jens; Lorenz, Ralf; Forstbauer, Helmut; Fink, Visnja; Bekes, Inga; Huober, Jens; Jückstock, Julia; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y; Heinrich, Georg; Häberle, Lothar; Fasching, Peter A; Beckmann, Matthias W; Coleman, Robert E; Janni, Wolfgang; Rack, Brigitte.
Affiliation
  • Friedl TWP; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Fehm T; Department of Gynecology and Obstetrics, University Hospital Duesseldorf, Heinrich-Heine University, Duesseldorf, Germany.
  • Müller V; Department of Gynecology, University Hamburg-Eppendorf, Hamburg, Germany.
  • Lichtenegger W; Charité University Hospital Campus Virchow, Berlin, Germany.
  • Blohmer J; Department of Gynecology and Obstetrics, Charité University Hospital Campus Virchow, Berlin, Germany.
  • Lorenz R; Gynecologic Practice Dres Lorenz, Hecker, Wesche, Braunschweig, Germany.
  • Forstbauer H; Hemato-Oncological Practice Dres Forstbauer and Ziske, Troisdorf, Germany.
  • Fink V; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Bekes I; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Huober J; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Jückstock J; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Schneeweiss A; National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Tesch H; Department of Oncology, Onkologie Bethanien, Frankfurt, Germany.
  • Mahner S; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Brucker SY; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tübingen, Germany.
  • Heinrich G; Oncological Practice, Fürstenwalde, Germany.
  • Häberle L; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Germany.
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Germany.
  • Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Germany.
  • Coleman RE; Sheffield Cancer Research Centre, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom.
  • Janni W; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Rack B; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
JAMA Oncol ; 7(8): 1149-1157, 2021 Aug 01.
Article in En | MEDLINE | ID: mdl-34165508
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: JAMA Oncol Year: 2021 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: JAMA Oncol Year: 2021 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos